December 7, 2007 - Edwards Lifesciences Corp. today has entered into a definitive agreement to sell certain assets related to the Edwards LifeStent peripheral vascular product line to C.R. Bard Inc. for up to $140 million. The transaction is expected to close in January 2008, pending regulatory approvals.
December 7, 2007 - Cardinal Health and HemCon Medical Technologies Inc. this week announced the availability of co ...
December 6, 2007 - The first commercial implant of the Mitroflow Aortic Pericardial Heart Valve in the U.S. was ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - More so than in previous years ...
December 6, 2007 - Boston Scientific Corp. welcomed the recommendation of a FDA advisory panel to approve with ...
By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - At this year’s RSNA more PACS ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
December 6, 2007 – Patients treated with a rotablator drill less risk of perforation than those treated with the excimer ...
December 6, 2007 — The Circulatory System Devices Advisory Panel to the FDA has recommended approval for the XIENCE V ...
Starion Instruments' TLS3 Tissue Ligating Shears feature Starion’s proprietary thermal welding technology, focusing ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 5, 2007 - The United Kingdom's Department of Health said today it will begin a new stroke strategy in which ...
December 5, 2007 - Bristol-Myers Squibb will divest its medical imaging division as part of an initiative to maximize ...
December 4, 2007 - Patients treated with Abbott Laboratories Inc.’s experimental drug-coated heart stent had low rates ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 4, 2007 - ELA Medical Inc. intiated U.S. enrollment in the OPTION study (Optimal Anti-tachycardia Therapy in ICD Patients without Pacing Indications), which will evaluate therapies and advanced algorithms in optimizing treatment and managing ICD patients.
December 4, 2007 – American College of Cardiology CEO Jack Lewin has urged ACC members this week to let "their members ...
December 4, 2007 - InSite One’s InDex Archive surpassed 1.5 billion individual images and over 20 million studies stored ...
December 06, 2007
